Agenus Inc.
ANTI-ILT4 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS
Last updated:
Abstract:
The present invention provides antibodies and antigen-binding fragments thereof that bind to ILT4 (immunoglobulin-like transcript 4) and combinations thereof, e.g., with an anti-PD1 antibody. Also provided are methods of use thereof, for example, for treating or preventing cancer in a subject; and methods of making such antibodies and fragments.
Status:
Application
Type:
Utility
Filling date:
3 Jun 2021
Issue date:
3 Feb 2022